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Abstract
Background:  Horizontal cells are retinal interneurons that modulate the output from
photoreceptors. A rich literature on the morphological classification and functional properties of
HCs in different animals exists, however, the understanding of the events underlying their
development is still limited. In most vertebrates including chicken, two main horizontal cell (HC)
subtypes are identified based on the presence or absence of an axon.
Results: In this work we have molecularly characterized three HC subtypes based on Lim1, Isl1,
GABA and TrkA, a classification that is consistent with three chick HC subtypes previously defined
by morphology. The axon-bearing and axon-less HC subpopulations molecularly defined by Lim1
and Isl1, are born consecutively on embryonic day (E) 3–4 and E4–5, respectively, and exhibit
temporally distinguishable periods of migration. Their relative numbers are not adjusted by
apoptosis. A sharp decrease of high endogenous levels of the activin-inhibitor follistatin at E3
coincides with the appearance of the Lim1 positive cells. Extending the follistatin exposure of the
HC retinal progenitor cells by injection of follistatin at E3 increased the number of both Lim1- and
Isl1 positive HCs when analysed at E9.
Conclusion: The results imply that the axon-bearing and axon-less HC subgroups are defined
early and are generated consecutively from a retinal progenitor cell population that is sensitive to
the inhibitory action of follistatin. The results are consistent with a model wherein added follistatin
causes HC-generating progenitors to proliferate beyond the normal period of HC generation, thus
producing extra HCs of both types that migrate to the HC layer.
Background
During the development of the vertebrate retina, five types
of neurons are born in a preserved sequential but overlap-
ping order [1-3]. These are retinal ganglion cells, horizon-
tal cells (HCs), amacrine cells, bipolar cells and
photoreceptors. In the mature retina, these cell types are
positioned within distinct laminas and can be further
divided into subtypes based on morphology, neurochem-
ical properties or function. At the end of the 19th century,
Ramón y Cajal recognized this complex lamination and
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morphological richness of the retina as well as identified
retinal subtypes based on morphology. Today, neuronal
subtypes are defined and distinguished by molecular and
functional criteria rather than by morphology. Approxi-
mately 50–70 neuronal subtypes can be identified in the
mature retina depending on the species [4,5].
Horizontal cells, which are the focus of this study, have
been found in all vertebrate retinas from fish to man [6,7].
They are interneurons situated between photoreceptors
and bipolar cells and form synapses with both cell types.
In the chick retina, HCs form a distinct layer of cells that
we will refer to as the horizontal cell layer (HCL), in the
outermost part of the inner nuclear layer (INL). Two kinds
of HCs are found in vertebrate retinas; axon-bearing and
axon-less HCs [6,7]. An exception are retinas from several
rodents, including mice, where only one HC type is iden-
tified [8]. In several species of fish, turtles, birds and mam-
mals (including primates) a third HC subtype have been
identified or suggested [4,6,9-12]. Regardless of the actual
number of HC subtypes, the axon-bearing HC is present
in all species and additional subtypes are axon-less [6].
The chick retina has three HC subtypes that have been
identified based on their distinct morphological appear-
ances [13,14]. One is the axon-bearing "brush-shaped"
HC (also denoted H1 or Type I) and the two others are
axon-less HCs, denoted "stellate" (or H2/Type II) and
"candelabrum-shaped" (or H3/Type III) HCs. The brush-
shaped HC axon-terminus mainly connects to rod pho-
toreceptors, whereas the dendritic trees of all three HCs
mainly form connections with cone photoreceptors
[13,15,16]. This functional organisation appears to be
conserved within vertebrate retinas [6,7].
A rich literature on the morphological and functional
properties of HC subtypes exists but less is known about
the developmental events underlying their generation.
Recent studies have demonstrated that transcription fac-
tors such as Foxn4, Ptf1a and Prox1 are pivotal for the gen-
eration of the axon-bearing HCs in mice [17-21], and
retinas deficient of the cell cycle inhibitors Ink4d and
Kip1 overproduce those HCs [22]. In addition to intrinsic
regulators like these, extrinsic factors are known to modu-
late different aspects of retinal development including
proliferation, determination, differentiation and cell sur-
vival/death. Members of the transforming growth factor
β/bone morphogenetic protein (TGFβ/BMP) family of
growth factors are known to function as modulators dur-
ing neuronal development [23] and an involvement of
these molecules during the generation of retinal neurons
have been suggested [24-30]. Follistatin which is an
endogenous inhibitor of activin, TGF-β 1, GDF-11, and
several other TGFβ/BMP molecules [27,31], is known to
be expressed in the developing retina and pigment epithe-
lium [24,25]. Interestingly, a recent study indicated that
the generation of HCs may be affected by follistatin [28]
since Prox1+ cells were found scattered at ectopic loca-
tions following virus mediated over-expression of follista-
tin in the developing retina.
The aim of this study was to gain further understanding of
how and when HC subtypes are generated. We have
molecularly characterized HC subtypes and found that
the transcription factors Lim1 and Isl1 are expressed in
axon-bearing and axon-less HC subtypes, respectively. We
demonstrate that the axon-bearing and axon-less HC sub-
populations are molecularly defined early in develop-
ment, have different but overlapping birth dates, migrate
to the HCL at different times and that their relative num-
bers are not adjusted by apoptosis. Endogenous follistatin
expression is high during the earliest phase of retinal
development, with levels dropping sharply at the time of
HC generation. Moreover, we show that follistatin overex-
posure at the time of HC-generation causes an increase in
both the early-generated Lim1+ axon-bearing and late
Isl1+ axon-less HCs when analyzed at embryonic day 9/
Hamburger & Hamilton stage 35 (E9, st35, [32]). Com-
bined, these results imply that the two HC subgroups are
defined early and are generated consecutively from a pro-
genitor cell population that is sensitive to follistatin inhi-
bition.
Results
Newly generated HCs express either Lim1 or Isl1 and 
constitute equally large populations
To identify immature HC subtypes several available anti-
bodies against molecules known to be involved in neuro-
nal determination were surveyed for reactivity to HCs. In
addition to the transcription factors Prox1 and Lim1 that
are expressed by immature HCs, Isl1 was identified as a
novel transcription factor expressed in immature HCs.
The result of the antibody survey is reported elsewhere
[33]. First we analysed whether all HCs expressed Prox1
and Pax6, two well established HC markers, using flat-
mounted retina sectioned through the HCL. The analysis
showed that all cells located within the HCL expressed
Prox1 and Pax6 (not shown). Stage 35 (E9) was selected
for further analysis since the HCL is established within the
INL at this age [34]. Retinas were analysed with respect to
Prox1, Lim1 and Isl1 expression. The results showed that
Lim1 and Isl1 immunoreactivities did not overlap, and
that Lim1 and Isl1 immunoreactive HCs were mixed
within the HCL (Fig. 1A). By counting double-labelled
cells in the HCL of the central-most retina, the ratio of
Lim1+ or Isl1+ HCs were determined to be 50/50 with
respect to Prox1 (Fig. 1B). These results reveal that HCs are
split into two equally large sub-groups based on the
expression of Lim1 and Isl1.BMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
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Isl1 HCs migrate one day after the Lim1 HCs
We have previously shown that HCs expressing Lim1 and
Prox1 perform a bi-directional migration within the retina
[34]. We investigated whether Isl1+ HCs performed a sim-
ilar bi-directional migration by comparing the patterns of
Lim1 (Fig. 1C–G), Prox1 (Fig. 1H–L, red) and Isl1 (Fig.
1H–L, green). The spatio-temporal pattern of Prox1+,
Isl1+ double-labelled cells was similar, but delayed to, the
Prox1+, Lim1+ double-labelled cells that have been
shown to migrate bi-directionally (compare Fig. 1C with
1J and 1E with 1L, single and double asterisks). The first
Prox1+, Isl1+ double-labelled cells were detected close to
the prospective ganglion cell layer (GCL) at st31 (Fig. 1H,
white arrows pointing at yellow cells). During subsequent
stages numerous Prox1, Isl1 double-positive cells were
seen scattered at various levels of the INL between st32
and st35 (Fig. 1H–L, yellow cells). Our analysis suggests
that Prox1+, Isl1+ double-labelled cells initiate retrograde
migration and reach the HCL one day after Lim1+ HCs.
Isl1 HCs are born one day after Lim1 HCs
To investigate if the segregated migration patterns
reflected a temporal difference in birth-dates or just a
delay in migration between the two subgroups, we birth-
dated the two HC populations using [3H]-dT. Stage 19–33
embryos received a single dose of [3H]-dT after which ret-
inas were collected at st35 (E9) and processed for Lim1
and Prox1 immunocytochemistry and autoradiography.
Stage 35 was analyzed since the mature 50/50 ratio of
Lim1+ and Isl1+ HCs is set at this stage (see below and Fig.
1B). The fractions of Lim1+ or Prox1+ HCs also positive
for [3H]-dT incorporation (silver grains) were determined
Horizontal cells express either Lim1 or Isl1 in equally large proportions Figure 1
Horizontal cells express either Lim1 or Isl1 in equally large proportions. (A): The HCL of a flat-mounted normal ret-
ina section labelled for Lim1 (red) and Isl1 (green) reveals that the expression patterns do not overlap. (B): Quantification of 
HCs expressing Lim1 or Isl1 with respect to Prox1 at st35 (expressed as % ± s.d., n animals = 3). (C-L): Comparison of the 
labelling patterns of Lim1 (C-G, green) and Prox1 combined with Isl1 (H-L, red/green) in st31-35 (E7–E9) retinas reveal that 
Lim1 and Isl1 HCs migrate (*) and reach the HCL (**) at different time points. White arrows in H indicate double-labelled cells. 
Scale bars are 20 μm (A) and 40 μm (L, valid for C-L).BMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
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for each injected stage (see Additional files 1 and 3). Since
other retinal cell types in addition to HCs label for Isl1
[33], we inferred the birth-date of Isl1+ HCs by analysing
the HCs expressing Prox1 but not Lim1.
Our data demonstrated that the HC population in the
central retina (Prox1+ HCs, Fig. 2 light grey bars) was born
between E3 and E6, in accordance with previous observa-
tions [1]. Furthermore, the birth of Lim1+ HCs peaked
between E3 to E4 (Fig. 2, dark grey bars), whereas the
birth of Prox1+, Lim1-negative HCs (deduced to be the
same as the Isl1+ HCs) peaked between E4 to E5 (Fig 2,
solid black line).
Lim1 is expressed by axon-bearing and Isl1 by axon-less 
HCs
We investigated how the Lim1 and Isl1 expressing HC
subgroups corresponded to the three HC subtypes previ-
ously identified by morphology [13]. Post-hatch day 7
(P7) retinas were analysed using confocal microscopy
with antibodies against the known HC markers calretinin,
GABA and TrkA [35-37] in relation to Lim1 and Isl1
expression. P7 retina was chosen since the morphology of
all three HC subtypes were difficult to assess at earlier
stages using immunohistochemistry.
Calretinin and Lim1 were co-expressed in HCs that had
morphology similar to the brush-shaped, axon-bearing
HC (compare Fig. 3A with 3E, Fig. 4D). Weak GABA label-
ling was detected in Lim1+ HCs (Fig. 3B, arrowhead)
while intense labelling was seen in a small subset of Isl1+
HCs (Fig. 3B, arrow). This intense labelling was found in
HCs with morphology similar to the axon-less stellate HC
(compare Fig. 3C with 3F). TrkA was found exclusively in
the majority of Isl1+ HCs (see below) that had morphol-
ogy similar to axon-less candelabrum-shaped HCs (com-
pare Fig. 3D with 3G).
GABA decreases in axon-bearing HCs from hatch to P7
GABA is considered to be the main neurotransmitter in
these inhibitory interneurons. Our results as well as others
show that GABA is present in a subset of HCs [38,39]. We
Lim1 and Isl1 horizontal cell subgroups have different birth-dates Figure 2
Lim1 and Isl1 horizontal cell subgroups have different birth-dates. Fractions of HCs positive for [3H]-dT incorpora-
tion combined with either Prox1 (light grey bars) or Lim1 (dark grey bars) analysed at st35 (expressed as % ± s.d., * p < 0.05 
using the Student's t-test, n = number of animals that were analysed for each stage). The line indicates the difference between 
the Prox1 and Lim1 [3H]-dT-labelled fractions, and represents the birth curve for Isl1+ HCs. Solid portion of the line corre-
sponds to significant differences. St: stage (of [3H]-dT injection), E: embryonic day.BMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
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compared GABA labelling in HCs from st44 (E18), P0, P4
and P7 chicks. At st44 (not shown) and P0, GABA label-
ling was uniform in both Lim1+ and Isl1+ HCs (compare
Fig. 3H–I, h and h') while at P4, a difference was notable
(not shown). At P7 GABA antibodies just weakly labelled
Lim1+ HCs whereas a subset of Lim1-negative HCs was
strongly labelled by GABA (Fig. 3J–K, j and j'). In sum-
mary, GABA levels gradually change in two of the sub-
types after hatching with high levels remaining in stellate
Isl1+ HCs, whereas GABA-levels in axon-bearing HCs
decrease.
Horizontal cell subtype population sizes
Horizontal cells from newly hatched P0 chick retinas were
labelled using combinations of antibodies directed
against Lim1, Isl1, Ap2α, Prox1, Pax6, GABA, calretinin
Confocal analysis of horizontal cell morphology and changes in GABA expression levels after hatch Figure 3
Confocal analysis of horizontal cell morphology and changes in GABA expression levels after hatch. (A): Axon-
bearing, brush-shaped HCs visualised by calretinin. (B): Flat-mounted P7 retina. GABA antibodies (red) label a fraction of Isl1+ 
HCs intensely (green, arrow, co-expression is yellow), and label Lim1+ HCs to a lesser extent (arrowhead). (C): Axon-less 
stellate HCs visualized by intense GABA labelling. (D): Axon-less candelabrum-shaped HCs visualised by TrkA. (E-G): Morphol-
ogy of chick HCs as they appear in Gallego, 1986 [6] with names and molecular attributes denoted below. (H-K): P0 (H-I) and 
P7 (J-K) HCs labelled for GABA (H-K, red) and Lim1 (H and J, green). Uniform GABA levels are found in both Lim1+ and Lim1-
HCs at P0 (compare h with h') whereas Lim1+ HCs express low levels of GABA at P7 (compare j with j'). Scale bars are 5 μm 
(valid for A-D and H-K).BMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
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and TrkA. All markers except Isl1 and Ap2α are previously
well established HC markers [18,34,36,37,40,41]. In the
P0 chick retina, Prox1 and Pax6 antibodies labelled all
HCs. Consistent with their expression at st35, Lim1 and
Isl1 did not overlap (not shown). Lim1 and Isl1 were
found in fractions of Prox1, Pax6 and GABA labelled HCs
(Fig. 4A–C, F–H). Calretinin was exclusively expressed in
Lim1+ HCs (compare Fig. 4D with 4I) and TrkA was
expressed in a fraction of Isl1+ HCs (compare Fig. 4E with
4J). GABA and TrkA labelling did not overlap (not
shown). Ap2α was expressed in all axon-bearing and
some axon-less HCs (Fig. 4K–O). At P0, Ap2α was
expressed in the majority of GABAergic HCs (Fig. 4M), in
all calretinin+ HCs (Fig. 4N), but not in TrkA+ HCs (Fig.
4O).
We quantified the fractions of cells single- or double-pos-
itive for these markers in the central retina (in direct prox-
imity to the optic nerve exit), and found that at P0, 50%
of all HCs expressed either Lim1 or Isl1, Ap2α was
expressed in 56% of all HCs, and GABA and TrkA was
expressed by 60% and 40% of all HCs, respectively (Fig.
4P–T). About 20% of the axon-less (Isl1+) HCs were
labelled for GABA, and the remaining Isl1+ cells for TrkA
(Fig. 4Q). Of all HCs expressing GABA at P0, 80% were
axon-bearing (Lim1+) HCs, whereas the remaining 20%
were of the axon-less stellate HC type (Fig. 4R). Quantifi-
cation with respect to calretinin confirmed the previous
observations of calretinin expression in axon-bearing HCs
(Fig. 3A and 4S).
Our data reveal the existence of two complementary divi-
sions of the HC population where Lim1 and Isl1 split the
HC population 50/50, and GABA and TrkA split the pop-
ulation 60/40. Combined, these divide the HC popula-
tion into three distinct groups where axon-bearing Lim1+
HCs constitute 50%, axon-less stellate HCs expressing Isl1
and GABA constitute 10% and axon-less candelabrum
HCs expressing Isl1 and TrkA constitute 40% of the HC
population (Figs 4T–U, see also 3E–G).
Apoptosis does not affect the Prox1+ HC population
To investigate whether apoptosis sculpted the relative pro-
portions of HC subtypes during early retinal develop-
ment, we performed TUNEL staining combined with
Prox1 antibody labelling in all developmental stages rang-
ing from st20 to st36 as well as in selected later embryonic
and post-hatch stages. We were unable to detect TUNEL
stained Prox1+ cells in any of the early stages we investi-
gated (Fig. 5A–F). At later retinal stages, a double-stained
cell could occasionally be found in the extreme peripheral
retina, but not in the early developing retina nor in the
central retina. TUNEL and Isl1+ double-labelled cells
belonging to other neuronal populations were observed
(not shown).
The onset of Lim1 expression is preceded by a drastic 
wave-like decrease of endogenous follistatin expression
Previous results have shown that over-expression of fol-
listatin in the developing retina results in ectopic cells
expressing Prox1 [28]. This observation prompted us to
further investigate the HC generation with respect to fol-
listatin. We analyzed the follistatin mRNA expression in
total retina from st14 to st45 embryos using qRT-PCR. The
levels were normalized to the house-keeping genes β-actin
and TATA-box binding protein. By far, the highest levels of
follistatin mRNA were in the optic cup and early eye (Fig.
6A, note logarithmic graph scale, see also Additional file
3). The mRNA levels dropped sharply until reaching rela-
tively very low levels between st23 and st30 (Fig. 6B, note
linear graph scale). The levels increased again after st35.
For comparison we analyzed the related factor follistatin-
like 1, which in contrast to follistatin was not develop-
mentally regulated (Fig. 6A–B). The drop in follistatin
mRNA levels between stages 18 and 25 (Fig. 6C and 6D)
coincides with the birth of Lim1+ HCs (Fig. 2).
Lim1 expression commences in the central retina at st19-
20 [33] and extends peripherally as development
progresses. At the early developmental stages, follistatin
immunoreactivity was strong in retina, lens and pigment
epithelium. With increasing age, a central to peripheral
gradient of different strengths of follistatin immunoreac-
tivity in the retina became progressively more obvious,
with the strongest immunoreactivity levels located in the
periphery (Fig. 6C and 6D, black arrows). The onset of
Lim1 expression followed close behind the decrease of
follistatin immunoreactivity as it moved towards the
periphery (Fig. 6C and 6D). As development progressed
(E4–E8), the endogenous expression of follistatin in the
central retina became restricted to cells located in the
putative GCL, whereas the expression in the central-outer
retina gradually waned (not shown). By st34 (E8), follista-
tin immunoreactivity was restricted to the GCL and to
cells located on the inner rim of the INL (see Additional
file 2).
Injection of follistatin at E3 decreases the number of newly 
generated Lim1+ cells
As retinal development progressed in a central to periph-
eral fashion, we observed that decreasing levels of follista-
tin immunoreactivity preceded the onset and expansion
of Lim1 expression. This inverse correlation between HC
generation and high follistatin levels suggested that fol-
listatin overexposure may interfere with the generation of
Lim1+ cells. We injected st21, st22 and st23 embryos with
follistatin or vehicle and analysed the number of Lim1+
cells in the central retina 22 h after the injection. The fol-
listatin bolus injection caused a significant 20–25%
reduction in the number of Lim1+ cells per mm2 retina in BMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
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Horizontal cell subtypes express different sets of markers Figure 4
Horizontal cell subtypes express different sets of markers. (A-O): The horizontal cell layer of flat-mounted P0 retinas 
labelled with Lim1 (A-E, green), Isl1 (F-J, green) and Ap2α (K-O, green), combined with Prox1 (A, F, K, red), Pax6 (B, G, L, 
red), GABA (C, H, M, red), calretinin (D, I, N, red) and TrkA (E, J, O, red). Double positive cells appear yellow. (P-S): Calcu-
lated fractions (expressed as % ± s.d., n animals = 3) of HCs co-expressing various markers with respect to Prox1 (P), Isl1 (Q), 
GABA (R) and calretinin (S). Asterisks in P denote that these fractions were calculated using known fractions of other markers. 
(T-U): Distribution of HC markers at P0 and P7. Scale bar is 20 μm (valid for A-O).BMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
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all stages tested (p < 0.05, Mann-Whitney test, Fig. 6E and
6F–G, see also Additional file 3).
The main target for the inhibitory action of follistatin is
activin [31,42], which is expressed in the developing ret-
ina [24] and is known to decrease cell proliferation in
many cell types and tissues [42]. We therefore hypothe-
sised that the reduction of newly generated Lim1+ cells by
the added follistatin, was an effect on the Lim1-generating
progenitor cells. The inhibitory action of follistatin would
then keep the progenitor cells proliferating and thus
delaying cells from exiting the cell cycle and turning on
Lim1 expression. This would lead to fewer newly gener-
ated Lim1+ cells compared to controls. To test this we
added BrdU 5 h after either follistatin or activin injections
to mark cells passing through S-phase. The number of
BrdU cells was analyzed after a total of 22 h. The activin
injections caused a robust decrease in BrdU incorporation
compared to controls (Fig. 7A–C, see also Additional file
3) while the follistatin injections did not lead to any con-
clusive changes (data not shown). This indicates that
activin treatment caused either an overall decreased prolif-
eration rate or caused retinal progenitor cells (RPCs) to
undergo premature cell cycle withdrawal. This finding
indirectly support the hypothesis that the bolus dose of
follistatin delays the onset of Lim1 expression by keeping
progenitor cells in a proliferative state.
Injection of follistatin at E3 affects retinal histology at E9
Effects on HCs can definitely be monitored first at st35
(E9), the time when both Lim1+ and Isl1+ HCs have
migrated to the HCL. We performed a series of injections
of follistatin into eyes of embryos ranging from st18-31.
Analyses of Prox1, Lim1 and Isl1 immunoreactivity were
then carried out at st35 (E9). We found that the structure
of the inner plexiform layer was frequently distorted in
embryos injected at early stages up to st24, but that no
obvious phenotype could be observed from st26 and
beyond (not shown). The typical follistatin-histology in
our experiment at st35 is consistent with Moreira and
Adler's observations [28], and was characterized by a thin-
ner inner plexiform layer (Fig. 8, compare A with B and C)
and ectopic Prox1+ cells either scattered or arranged in
columns spanning the GCL and/or INL (Fig. 8B and 8E,
brackets). This phenotype served as our criterion to deter-
mine if a retinal region had been affected by follistatin,
and images from such regions were acquired and used for
further analysis.
Follistatin produces ectopic horizontal cells that migrate 
back to the HCL
The expression of Prox1, although at ectopic locations in
the st35 (E9) retina, hinted that the cells were HCs. We
wanted to know whether the ectopic Prox1+ cells were in
fact HCs and investigated if they in addition to Prox1
expressed Lim1 or Isl1. Embryos were analysed with
respect to HC development at st35. Some of the retinas
were analysed one day later at st36 (E10). This relatively
long post-injection time of 6–7 days was chosen in order
to ensure the correct identification and quantification of
HC subtypes, based both on their marker expression and
localization in the retina.
Double immunohistochemistry for Prox1, Lim1 and Isl1
(Fig. 8A–E) showed that the ectopic Prox1 cells seen at
st35 expressed either Lim1 or Isl1, indicating that ectopic
Prox1+ cells were bona fide HCs. Consistent with our pre-
vious results, we did not observe Lim1 and Isl1 co-expres-
sion in control or follistatin-treated retinas (not shown).
The ectopic cells in the st35 retina were predominantly of
the Prox1, Isl1 double positive HC subtype (Fig. 8B and
8E, white arrows) and only a fraction of the ectopic
Prox1+ cells expressed Lim1 (Fig. 8E, black arrow). One
day later at st36/E10, ectopic HCs could not be found
(Fig. 8C). Since the total number of cells double-positive
for Prox1 and Lim1 or Prox1 and Isl1 (i.e. the ectopic cells
and the ones present in the HCL) were similar in st35 and
st36 retinas (data not shown), and apoptosis was not
detected in normal or ectopic Prox1+ cells as shown by
TUNEL (Fig. 8F), it was concluded that the st35 ectopic
HCs had migrated back to the HCL at st36 (compare Fig.
8B and 8C, single and double asterisks) following a nor-
mal although delayed migration route.
Horizontal cells are not affected by apoptosis Figure 5
Horizontal cells are not affected by apoptosis. (A-F): 
Stage 21 (A), 24 (B), 27 (C), 29 (D), 31 (E) and 35 (F) retinas 
stained for TUNEL (green) and Prox1 (red) reveal no overlap 
between the two signals. Scale bars: 20 μm (B and F are valid 
for A-B and E-F).BMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
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Injections of follistatin at E3 increase the number of HCs 
at E9
When analysing regions containing ectopic Prox1+ cells it
appeared as if the number of Prox1+ HCs had increased.
This was in contrast to the results obtained for Lim1+ cells
22 h after follistatin administration. We injected follista-
tin in a series of embryos at the phase of HC generation.
As shown by the HC birth-dating experiments (Fig. 2),
st20 and st23 correspond to the initial phases of the gen-
eration of the two HCs populations, respectively. This
period also corresponds to when the endogenous follista-
tin levels drop (Fig. 6A–B). Controls were injected with
Decreased follistatin expression coincides with the generation of horizontal cells Figure 6
Decreased follistatin expression coincides with the generation of horizontal cells. (A-B): Follistatin (solid line) and follistatin-
like 1 (FSTL1, dashed line) mRNA levels during retinal development relative the lowest value respectively which is set to 1 (follistatin: 1 = 
st28; FSTL1: 1 = st42). The X-axis denotes the embryonic stages analysed and the Y-axis denotes the relative mRNA levels in log scale (A) 
or linear scale (B). Numbers in parenthesis in B denote the relative follistatin mRNA level-value at st18 and 38, respectively. (C-D): Fol-
listatin immunoreactivity (red) in the developing retina at st22 (C) and st25 (D) reveal a central-to-peripheral gradient of follistatin 
expression. Highest levels are expressed peripherally and sharp boundaries between high and low expression are evident (black arrows). 
The onset of Lim1 expression (green) is trailing the wave-front of decreasing follistatin expression. (E): 22 h after follistatin treatment at 
st21, st22 or st23, the number of Lim1+ cells decreases by approximately 20–25%. Lim1+ cells were counted in 20× visual fields and 
expressed as Lim1+ cells/mm2 retina. Blue squares indicate the means of individual control treated animals and red circles indicate the 
means of individual follistatin-treated animals. The medians are indicated by a black line, * denote significant differences (p < 0.05, Mann-
Whitney test). F-G: Lim1 expression (green) in central retina 22 h after control (F) or follistatin (G) treatment in st22 embryos. Scale bars 
are 100 μm (C-D), and 20 μm in G (valid for F-G).BMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
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vehicle at st21 or st23. We counted cells double-positive
for Prox1 and Lim1, and Prox1 and Isl1 at st35, in retinas
treated with follistatin at st20, 21, 22 or st23 and each
stage was then compared individually with controls
treated with vehicle at st21 or st23.
If the st20 treatment preferentially had effects on the early
Lim1 population and not on the later Isl1 population,
while the st23 treatment had effects on the late popula-
tion, it could be hypothesized that the Lim1 and Isl1 HC
subtypes are generated from separate progenitor cells.
Conversely, if the early follistatin treatment also had
effects on the late population it is likely that both subtypes
are generated from a common pool of progenitor cells
that is affected by the follistatin inhibition and expanded.
We found that follistatin treatment at all 4 stages caused a
significant increase in the total number of HCs (Prox1+)
as well as significant increases in both the number of
Lim1+ and Isl1+ HC subtypes compared to controls (Fig.
8G–I, see also Additional file 3). With respect to the
number of Lim1+ or Isl1+ cells in follistatin-treated ani-
mals, we found no difference between the early and late
injection stages (Fig. 8G–I). Over all, the increase in the
total number of Prox1+ cells was approximately 30%, for
Lim1, Prox1 double positive cells approximately 40%,
and for Isl1, Prox1 double positive cells approximately
50% (means of the 4 stages, see also Additional file 3).
Thus, our data showed that follistatin overexposure at
st20, 21, 22 or st23 caused an over-production of both the
Lim1+ and the Isl1+ HC subtypes when analyzed at st35,
regardless of the stage of treatment.
Follistatin treatment and the effects on other retinal cell 
types
We analysed whether follistatin treatment at st23 influ-
enced the generation of cell types other than HCs by
quantifying the number of cells carrying markers against
photoreceptors (Lim3, Isl1/2), amacrine cells (Ap2α),
bipolar cells (Lim3, Isl1) and ganglion cells (Isl1) in st35
retinas [33]. We did not detect any differences in the
number of immunoreactive cells in the outer nuclear layer
after follistatin treatment using Lim3 (Fig. 9A–B) or Isl1/
2 antibodies (Fig. 8A–C and 9E–F). The cells in the outer
nuclear layer labelled by the Isl1/2 antibody most likely
correspond to Isl2+ cells, since labelling with another Isl1
specific antibody did not produce immunoreactivity in
these cells (not shown). In the INL, the bipolar cell popu-
lation marked by Lim3 and Isl1 (Fig. 9A–B and 9E–F), and
the amacrine cell population marked by Ap2α (Fig. 9C–
D) were not affected by the follistatin treatment (Fig. 9H–
I). In the GCL we did not detect any significant differences
in the number of Isl1+ cells compared to controls (Fig.
8A–C and 9E–F, I). Noteworthy is that due to loss of inner
plexiform layer thickness following follistatin treatment,
we could not distinguish Isl1+ ganglion cells from Isl1+
amacrine cells normally present in the inner nuclear- and
plexiform layers (compare Fig. 8A and 8B). Therefore, the
Isl1 cell-counts in figure 9I include both these cell types.
These data are also summarized in Additional file 3. These
Decreased BrdU incorporation following activin treatment Figure 7
Decreased BrdU incorporation following activin treatment. BrdU incorporation was assayed in st23 activin treated 
retinas (A) and control injected retinas (B) using immunohistochemistry. After activin treatment, BrdU incorporation was 
markedly reduced compared to controls (compare a and b). (C): When quantified, this reduction was found to be significant (* 
p < 0.05, Mann-Whitney test). Blue squares indicate the means of individual control treated animals and red circles indicate the 
means of individual activin-treated animals. The medians are indicated by a black line. Scale bars B and b are 100 μm and 50 μm, 
respectively (valid for A-B and a-b).BMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
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data suggest that under these experimental conditions,
HCs is the only cell type that is affected by the follistatin
treatment at st23.
Discussion
Horizontal cell subtypes and their maturation
In this work we have demonstrated that HCs are generated
as two equally large and distinct subgroups during early
retinogenesis. One subgroup, corresponding to the axon-
bearing HC, expresses Lim1 whereas the other subgroup,
corresponding to the axon-less HCs, expresses Isl1. The
Follistatin treatment at E3 increase the number of horizontal cells at E9 Figure 8
Follistatin treatment at E3 increase the number of horizontal cells at E9. (A-F): Retinal cross-sections stained for Prox1 (A-F, 
red) combined with Isl1 (A-C, green), Lim1 (D-E, green) or TUNEL (F, green). Co-labelled cells appear yellow. Compared to st35 control 
retinas (A and D) follistatin treated retinas (B, C and E) have ectopic Prox1+ cells in the inner retina which are often arranged in columns 
(B and E, brackets). These ectopic Prox1+ cells are primarily of the Isl1+ HC subtype (white arrows), although some are Lim1+ (E, black 
arrow). (C): At st36, ectopic HCs have migrated to the HCL (compare double asterisks with single asterisk in B). (F): St35 Prox1 and 
TUNEL-staining reveal no overlap. (G-I): Quantification at st35 of the number of HCs in 40× visual fields following follistatin treatment at 
various E3-stages. Blue squares indicate the means of individual control treated animals and red circles indicate the means of individual fol-
listatin-treated animals. The medians are indicated by a black line. Follistatin causes a significant increase in the number of HCs (Prox1+) 
and HC subtypes (Lim+ or Isl1+ HCs) at all stages, compared to controls (* p < 0.05, Mann-Whitney test, see also Additional file 3). Scale 
bar is 20 μm (valid for A-F).BMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
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axon-less (Isl1+) HC subpopulation can be further subdi-
vided in two HC subtypes. The Lim1 and Isl1 HC sub-
groups are generated and then migrate bi-directionally in
the developing retina during successive periods. Moreo-
ver, we show that retinal progenitor cells that are able to
generate both Lim1 and Isl1 HCs respond to follistatin
overexposure at E3. The treatment results in significant
increases in both Lim1 and Isl1 HC subtypes at E9. This
effect is specific to HCs, and is best explained by a sus-
tained proliferation of HC-generating progenitor cells.
Effects on other cell populations following follistatin treatment Figure 9
Effects on other cell populations following follistatin treatment. Control (A, C, and E) or follistatin-treated retinas (B, D, and F) 
stained for Prox1 (A-F, red) and Lim3 (A-B, green), Ap2α (C-D, green) and Isl1 (E-F, green). All injections were made at st23 and analysed 
at st35. With respect to the thickness of immuno-labelled bands, all markers appear grossly normal after follistatin injection. (G-I): Quan-
tification of immuno-labelled cells in 40× visual fields. Blue squares indicate the means of individual control treated animals and red circles 
indicate the means of individual follistatin-treated animals. The medians are indicated by a black line. Using the above markers, no signifi-
cant differences (p < 0.05, Mann-Whitney test) were found between control or follistatin treated retinas with respect to the number of 
photoreceptors, bipolar cells, amacrine cells or ganglion cells. Note that the Isl1+ cells quantified in 9I include both Isl1+ ganglion and 
amacrine cells. Scale bar is 20 μm (valid for A-F).BMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
Page 13 of 21
(page number not for citation purposes)
We have demonstrated two types of axon-less HCs, the
stellate and candelabrum-shaped HCs that in addition to
Isl1, express GABA and TrkA, respectively. The axon-bear-
ing brush-shaped HCs express calretinin in addition to
Lim1. We quantified the proportions of the HC subtypes
in the central P0 chick retina and found that the axon-
bearing brush-shaped HC and the axon-less stellate and
candelabrum-shaped HCs constituted 50%, 10% and
40% of the HC population, respectively. These findings
are consistent with previous reports on chick HCs
[6,13,38,39,43]. However, in slight contrast to our find-
ings one recent report demonstrated that in P7–P21 chick
retina a small fraction of Isl1+ HCs express calretinin [38],
an observation that is not supported by our P0 retinal
preparations and it is therefore possible that a subset of
Isl1+ HCs turn on calretinin expression after hatching.
The same study also identified what was classified as a
fourth HC subtype based on their analysis of HC markers.
A fourth HC subtype is also described in the pigeon retina
based on morphological criteria [12]. Our results support
the classical division of chick HCs into three main sub-
types [6,13] but the actual number and extent of heteroge-
neity in HC subtypes in the chick retina is an unsettled
issue.
As the retina undergoes late maturation, synapse rear-
rangement and changes in the expression levels of various
proteins are known to occur [44-46]. We found that GABA
was initially present uniformly in all GABA-containing
HCs, but that GABA levels progressively decreased in
axon-bearing HCs and increased in axon-less stellate HCs
after hatch. This implies that GABA has a role in adult stel-
late HCs but not in adult axon-bearing cells. Rather, GABA
may have a transient function in the developing axon-
bearing HCs. This is in agreement with a role for GABA
during synapse maturation when connections between
HCs and photoreceptors or bipolar cells are established
[47]. Other studies have reported changes in GABA levels
during phenotypic maturation of HCs in rats, rabbits,
guinea pigs and humans [48-51].
Early development of HC subtypes
Most classes of retinal neurons undergo cell death during
development [52]. Photoreceptors and HCs are likely
exceptions to this rule [53] and it has been shown that
HCs do not undergo apoptosis during later stages of
development [54,55]. We investigated apoptosis in HCs
using TUNEL during early (Fig. 5) and late retinal devel-
opment (not shown), but could not find evidence to sug-
gest that the HC population size was adjusted by
apoptosis. Moreover, Lim1+ HCs have been shown to
migrate bi-directionally across the retina [34] and in this
study we show that the Prox1, Isl1 double positive HCs
followed a similar but delayed pattern, migrating approx-
imately one day later (compare asterisks in Fig. 1C–L, Fig.
10A). Hence, we concluded that Isl1+ HCs also undergo
bi-directional migration.
We investigated whether the two HC subpopulations
marked by Lim1 or Isl1 were born simultaneously or con-
secutively by performing a birth-dating analysis using
[3H]-dT incorporation. Our results revealed that although
the two birth-curves overlapped, the majority of Lim1+
HCs were born between E3 and E4 whereas the majority
of the HCs expressing Isl1+ were born between E4 and E5
(Fig. 2). However, since the earliest stage when Isl1+ HCs
can be positively identified using Prox1 is st31 (Fig. 1H,
arrows), the lack of earlier HC subtype markers makes it
difficult to state with certainty that HC progenitors that
give rise to the Isl1+ HCs are in fact born into an Isl1-fate
(and not born as Lim1+ cells). However, the birth-curve of
the Isl1+ HCs is concomitant with the appearance of
Prox1+, Lim1-negative cells in the retina between E5.5
and E7 [34]. These Prox1-single positive cells likely corre-
spond to the Isl1+ HC fraction before the actual onset of
Isl1 expression. Thus, the birth-dating results inferring
that Isl1+ HCs undergo their last S-phase around E4–5,
which is just prior to the appearance of Prox1-single pos-
itive cells at E5.5, supports a scenario where the late HC
subgroup identity is established at the time of cell cycle
withdrawal. In addition, we do not find any Isl1 and Lim1
double labelling in HCs (Prox1+ cells) after st31. God-
inho et al recently used live imaging in the zebrafish retina
to show that the mitoses generating HCs occurred in the
INL [56]. Combined, these data opens up the possibility
that HCs in chick are generated as cells committed into
distinct fates (Lim1/early or Isl1/late), and that the gener-
ation of these subgroups is temporally separated.
The results from a recent lineage study of chick HCs sug-
gested that there was no significant difference in the birth
order among three identified HC subtypes [57]. Our
birth-dating experiment only considered HCs in the very
central part of the retina and as the generation of HCs pro-
ceed further peripherally in the retina the temporal over-
lap of the generation may be larger. This may explain the
discrepancy between the different results. In addition, the
two waves of migration to the HCL also imply a consecu-
tive generation of the subtypes.
The separate birth-dates and migration periods reveal the
existence of temporal windows during which HC precur-
sors can acquire different fates. For instance, the genera-
tion of stellate HCs could result from a combination of
instructive signals acting at overlapping time points. Stel-
late HCs could be generated during an overlap of: a) a
decreasing signal instructing early born HCs to express
Ap2α and GABA, and b) an increasing signal instructing
late-born HCs to express Isl1. The 6–10% abundance of
Ap2α and GABA expression in the stellate HCs may sug-BMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
Page 14 of 21
(page number not for citation purposes)
gest such a mechanism (Fig. 4T). In this scenario, later
born Isl1+ HCs (i.e. the TrkA+ candelabrum HCs) would
encounter only the second signal and develop along a
third route. These potential signals remain to be character-
ized and may be either extrinsic, intrinsic or both. The sig-
nals seem not to be of a character that could be inhibited
by follistatin since the subpopulations were not differen-
tially affected by this treatment.
Schematic summary of horizontal cell development Figure 10
Schematic summary of horizontal cell development. (A): Schematic figure of the generation and migration of Lim1+ and Isl1+ 
HCs. S and M denote stages of the cell cycle. Position of M-phase cells is according to the classical view, however see also Godinho et al 
[56]. (B): Proposed model for the effects of follistatin on RPCs during retinogenesis. During normal development, high follistatin levels 
stimulate the proliferation of RPCs by preventing e.g. activin (or related factors) to decrease or inhibit proliferation. As follistatin 
decreases over time, RPCs specialize to generate e.g. HC progenitors. Under the influence of exogenous follistatin, again preventing 
activin (or related factors) from controlling cell cycle withdrawal, proliferation in the HC generating progenitor pool is stimulated and 
therefore, more HCs than normal are eventually generated.BMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
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Follistatin promotes the proliferation of HC-generating 
progenitor cells
In the developing retina extrinsic signals, exemplified by
the TGFβ/BMP family members, are suggested to regulate
nearly every aspect of retinal development, such as prolif-
eration, migration, fate determination, cell death and
functional maturation [26,27,29,58,59]. Follistatin, a
potent inhibitor of activin and several other members of
the TGFβ super family have previously been implicated to
take part in the differentiation of retinal neurons
[24,25,28]. For instance, a recent study indicated that fol-
listatin could interfere with the generation of neurons in
the developing retina, and also showed that follistatin was
able to down-regulate the activin-dependent pSmad2
[28].
The central-to-peripheral temporal gradient of retinal
development, where the central regions of the retina are
more mature relative the peripherally located regions, is
well characterized and makes the spatio-temporal aspect
of retinal development an important factor to consider.
Therefore, to understand how follistatin activity in the ret-
ina relates to our birth-dating of HCs as well as to the
appearance of the early HC marker Lim1, we characterized
the spatio-temporal follistatin expression. We found that
follistatin expression followed a central-to-peripheral pat-
tern and that with increasing age the immunoreactivity in
the central retina decreased and an apparent wave-front of
high follistatin expression moved towards to the periph-
ery. The appearance of Lim1+ cells followed close behind
this moving wave-front (Fig. 6C and 6D, black arrows).
Combined with our qRT-PCR data demonstrating a dra-
matic 50-fold drop in follistatin mRNA levels that coin-
cided with the time of HC birth, our observations show a
correlation between low follistatin levels and HC genera-
tion.
In several cells and tissues, follistatin promotes prolifera-
tion by removing the inhibition of cell proliferation
exerted by activin [42]. Our observations indicate that this
is also true in the developing retina. For instance, activin
injections in E3 embryos caused a robust decrease in BrdU
incorporation (Fig. 7A–C), and during E2 (st14-18),
which is a time marked by massive RPC proliferation in
the developing retina, the relative levels of follistatin
mRNA were extremely high (Fig. 6A). Combined, these
observations indicate that follistatin stimulate prolifera-
tion in the retina, possibly by repressing activin signalling.
Interestingly, the notion that follistatin stimulates prolif-
eration may appear inconsistent with the observation that
embryos injected with follistatin and analysed 22 h after
the injection had fewer Lim1+ cells than control-treated
embryos. Our interpretation is that the transient follista-
tin overexposure prevents HC-generating progenitor cells
from producing post-mitotic cells, which turn on Lim1
expression. Instead, the affected progenitor cells may pro-
duce two mitotic daughters (not yet expressing Lim1) that
will both inherit the capability to produce HCs. Thus,
with a follistatin-induced increase of the HC-generating
progenitor pool, the observed result will be a delayed
onset of Lim1 expression, followed by an increase in the
total number of HCs at a later time point (e.g. at E9), and
this is what our results showed. Combined, these observa-
tions suggest that follistatin is important for early RPC
proliferation in general and specifically for the prolifera-
tion and generation of HC progenitor/precursor cells (Fig.
10B). However, since the follistatin-phenotype at E9
(st35) most often was restricted to distinct regions of the
retina, this indicates the existence of a spatio-temporal
window during which HC-generating progenitor cells are
susceptible to follistatin treatment which give rise to the
described effects.
Moreover, embryos injected with follistatin at E3 and ana-
lysed at E9 (st35) had a significantly increased number of
HCs. This increase was slightly more pronounced in the
later-born Isl1+ HCs (approximately +50%) compared to
the early Lim1+ HCs (approximately +40%) (Fig. 8, com-
pare H and I, see also Additional file 3). Furthermore, the
ectopic HCs scattered within the retina at st35 in follista-
tin-treated retinas were predominantly of the Isl1 subtype
(Fig. 8B and 8E). One day later, at st36, these ectopic cells
were no longer observed and we concluded that they had
settled in the HCL (Fig. 8B and 8C), since the increased
number of Prox1, Isl1 double positive HCs was similar in
st35 and st36 retinas. Moreover, TUNEL staining was not
detected in these cells (Fig. 8F). Our conclusion is that the
ectopic and migrating HCs at st35 represent HCs that were
produced in excess following follistatin treatment. This is
in agreement with a model wherein follistatin cause HC-
generating progenitor cells to proliferate beyond the nor-
mal period of HC generation, thus producing extra HCs
that also migrate to the HCL.
Follistatin inhibits the action of ligands such as activin
and other TGFβ-signalling molecules by binding them
and thus preventing subsequent receptor activation.
Hence, the inhibitory effects of follistatin depend on the
presence of these ligands. Activin and its receptors are
known to be present in the developing retina [24] and
therefore activin stands out as a likely candidate through
which follistatin exerts its inhibitory action. However, it
cannot be excluded that the effects caused by follistatin
treatment are generated by the inhibition of other TGFβ-
signalling systems, or that the follistatin treatment may
mediate its effects by indirectly influencing other cell sig-
nalling systems. Regardless of the pathway(s) by which
follistatin affects retinal development at E3, our data sug-
gest that the effects are exclusive to progenitor cells that
generate HCs since we were unable to detect any differ-BMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
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ences in the number of other retinal cell populations at E9
following follistatin treatment at st23 (Fig. 9G–I, see also
Additional file 3). This was perhaps surprising, consider-
ing the broad spectrum of ligands which follistatin can
bind and inhibit, and also considering that classic lineage-
tracing experiments have shown that early RPCs are
homogeneously multipotent and capable of generating all
retinal cell types [60,61].
The result that the other major retinal cell populations
studied were not affected by follistatin might, however, be
explained by one or more mechanisms. First, compared to
HCs, most retinal cell populations are generated over a
long period of time, which allows for secondary mecha-
nisms to control proliferation and cell-fate decisions. This
can be exemplified by post-mitotic amacrine cells and
ganglion cells that through feedback inhibition to progen-
itor cells control the continued generation of these cell
types, respectively [62,63]. In addition, apoptosis may
also provide a mechanism by which, from E3 to E9, cell
numbers are adjusted and corrected. Secondly, the brief
overexposure-time of follistatin in our experimental setup
may be insufficient to produce effects that would require
long-term follistatin exposure, and may explain the incon-
sistency between our and Moreira and Adler's observa-
tions that following their continuous follistatin-
overexposure, the region containing Ap2α amacrine cells
decreased in thickness [28]. Thirdly, one may hypothesise
that progenitor cells, which generate other retinal popula-
tions than HCs at E3 (for instance retinal ganglion cells
and cone photoreceptors), rely on other signalling sys-
tems than follistatin to control their proliferation rate.
Supporting this view are previous studies reporting that
certain RPCs are biased to produce only a limited reper-
toire of neurons [56,64-66]. These three explanations are
not mutually exclusive; however, based on our and other's
data, we favour an explanation that assumes a degree of
heterogeneity in the early RPC pool.
Horizontal cells are in several ways the odd ones out when
compared to other retinal neurons. For example, HCs
undergo bi-directional migration, and in contrast to most
retinal cell populations, HC cell numbers are not adjusted
by apoptosis, neither during early nor late development.
As shown here, HCs are the only cell type that is affected
by follistatin at E3, which suggests that progenitor cells
that are competent to generate HCs are follistatin-sensi-
tive, whereas progenitor cells that generate other early-
born neurons, e.g. cone photoreceptors are not. In line
with this, the existence of progenitor cells biased for HC
generation have been indicated in mice [66] where Zhang
et al. found using Cre-LoxP fate-mapping that an
enhancer element of Pax6 was active in a restricted subset
of RPCs, which almost exclusively generated HCs. The
recent work by Godinho et al in zebrafish [56] and the lin-
eage study in chick by Rompani and Cepko [57] both
shows that there are progenitor cells fated to generate HCs
by a final mitosis. Rompani and Cepko's data suggest that
such dedicated HC progenitors are biased to generate two
HCs of only one subtype.
Our results showed that the generation of both Lim1+ and
Isl1+ subtypes were affected by the follistatin injections at
st20-23 (Fig. 8G–I). Assuming that the effect by the early
bolus injection of follistatin is transient and that it is
washed out before the peak of Isl1+ HC generation, our
data agree with an interpretation that progenitors are
committed to a HC fate before their terminal mitosis or
even before they undergo their last S-phase. This interpre-
tation is consistent with the observation that pre-mitotic
HC precursors in zebrafish bear morphological resem-
blance to HCs themselves and also express Ptf1a and
Cx55.5 that are normally found in post-mitotic HCs [56].
Conclusion
Axon-bearing and axon-less HC subtypes express Lim1
and Isl1, respectively. These two subtypes are born
sequentially and their relative proportions are fixed early
in development and are not adjusted by apoptosis. HCs
are generated concomitantly with a decrease in endog-
enous follistatin levels. Adding exogenous follistatin at E3
clearly affected progenitor cells competent to generate
HCs, and caused an over-production of HCs (Fig. 10B).
Taken together, our data suggest that HC progenitors are
sensitive to follistatin and become committed to produce
Lim1+ and/or Isl1+ HC subtypes concomitantly with or
early after their own generation.
Methods
Animals and in ovo cultures
Fertilized White Leghorn eggs (Gallus gallus) were
obtained from Ova Produktion AB (Västerås, Sweden)
and incubated at 38°C in a humidified incubator (Maino,
Italy). Embryos were staged according to Hamburger and
Hamilton [32]. Hatched chicks were kept at the animal
facility at Evolutionsbiologiskt centrum, Uppsala. The
animal work followed the EC guidelines and the ARVO
statements for use of animals in ophthalmic and vision
research. Experiments were scrutinized by the local ani-
mal ethics committee.
Tissue preparation for immunohistochemistry
Whole eyes or a patch of the central-most retina were dis-
sected and fixed in 4% PFA for 15–20 minutes, washed 10
minutes in PBS and cryoprotected in 30% sucrose for 3–4
hours before being frozen in OCT (Sakura). Dissected ret-
ina was flat-mounted onto nitrocellulose filters. Tissues
were cryosectioned and collected on Superfrost Plus
glasses (Menzel-Gläser). Flat-mounts were cut in 10 μm
thick sections in a plane parallel to the filter producingBMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
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sections through each retinal lamina. Cross-sections of the
central retina were cut along the naso-temporal axis at 10
μm or 20 μm. Immunohistochemistry was preformed as
described elsewhere [34].
Antibodies
Primary antibodies; Prox1 (1:1000, rabbit, AB5475,
Chemicon), Lim1/2 (1:20, mouse, 4F2, Developmental
studies hybridoma bank (DSHB)), Ap2α (1:200, mouse,
3B5, DSHB), Pax6 (1:200, mouse, PAX6, DSHB and
1:4000, rabbit, AB5409, Chemicon), Isl1/2 (1:200,
mouse, 40.2D6, DSHB, [67]) and Isl1 (1:10000, guinea
pig, gift from Prof. J. Ericson), GABA (1:1000 rabbit,
A2052, Sigma), Calretinin (1:1000, rabbit, 1741-1007,
Anawa), TrkA (1:4000, rabbit, gift from Prof. L. Reichardt
[68]), BrdU (1:500, mouse, B8434, Sigma), follistatin
(1:100, goat, sc-23553, Santa Cruz) and Lim3 (1:200,
mouse, 67.4E12, DSHB). Secondary antibodies were
obtained from Vector Laboratories, Jackson Immunore-
search Laboratories or Molecular Probes.
Microscopy and image processing
Samples were analysed using a Zeiss Axioplan2 micro-
scope or a Zeiss LSM 510 confocal microscope, equipped
with Axiovision software or LSM 510 imaging software
(v3.2), respectively. Images were formatted, resized,
enhanced and arranged for publication using Axiovision,
LSM image browser and Adobe Photoshop. Graphs were
made in Prism (v3.02, GraphPad software Inc.).
In ovo embryo cultures
For the birth-dating experiment and follistatin/control
injections, fertilized eggs were removed from the incuba-
tor on E2 or E3 and 3 ml egg white was aspirated from the
egg to allow the yolk and embryo to detach from the
inside of the eggshell. A small window was made in the
eggshell above the embryo and re-sealed with transpore
tape (3 M). Embryos were returned to the incubator and
allowed to develop until the desired stage when manipu-
lations were carried out. After manipulation, the windows
were again re-sealed with tape and the eggs returned to the
incubator where the embryos were allowed to develop
until the time of analysis.
Intra ocular follistatin injections
The eye of st20-23 (E3) embryos were microinjected with
<0,2 μl follistatin (PeproTech, 1 μg/μl in PBS) using glass
capillaries. Control injections contained vehicle. The solu-
tions were supplemented with Fast Green (Kodak) in
order to visualize the injected solution. Embryos were
allowed to develop to st35-36 (E9–10) when injected eyes
were processed for immunohistochemistry. The survival
at st35 was typically 20–30% for both vehicle and follista-
tin injections.
Upon macroscopic inspection, injected eyes appeared
normal when compared to un-injected and contralateral
eyes. Deviations from normal appearance were rare. His-
tologically, the follistatin phenotype was not evenly
spread over the retina but rather confined to distinct
zones, so in order to select regions for cell counting (see
below) the histological phenotype described in the
Results part served as our criteria to determine if a retinal
region had been affected by the follistatin. Un-affected
regions were most often found in the periphery. Approxi-
mately 20% of the follistatin treated survivors did not pro-
duce a clear histological phenotype and were omitted
from further analysis.
Cell quantification and statistical analysis
The distribution of HC subtypes may vary with retinal
location [43,69], thus all cell counts were performed in
samples taken from the central retina. The region directly
opposite to the lens and/or in proximity to the optic nerve
exit was considered as central retina. HC counts were
based on the assumption that Prox1 labels all HCs.
Cell quantification in developing embryos: 10 μm cross-
sections of normal, follistatin or vehicle injected eyes were
labelled using immunohistochemistry as described above.
For HC quantification in st35 and st36 embryos, fluores-
cence micrographs of sections with Prox1 labelling in
combination with Lim1 or Isl1 were acquired using the
40× objective on an Axioplan2 microscope. The number
of cells positive for Prox1 alone, or Prox1, Lim1 double
positive-, and Prox1, Isl1 double positive cells was deter-
mined from two series of injections using a minimum of
4 individuals surviving the injections per stage as indi-
cated in figures and legends. A minimum of 4 micro-
graphs from 4 retinal sections per animal were used for
cell quantification, which was facilitated by Photoshop
and ImageJ (NIH). Statistical analyses were performed in
Prism (v3.02, GraphPad software Inc.) using the Mann-
Whitney test and p-values < 0.05 were considered signifi-
cant (see also Additional file 3). For quantification of
other cell populations than HCs following follistatin
treatment, the same retinas used for HC quantification
above were immuno-labelled using various markers. Cell
counting and statistical analysis was done as described
above.
To test the effects of follistatin injections on the number
of Lim1+ cells early in development, st21, st22 and st23
eyes were injected with follistatin or vehicle as described
above and processed for Lim1 immunohistochemistry 22
h after the injections (number of animals analysed per
stage is indicated in Fig. 6E and Additional file 3). Images
from central retina were obtained from 5 sections per
embryo using a 20× objective and the number of Lim1+
cells was quantified using Photoshop and ImageJ. TheBMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
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area of the cross-sections was determined using Axiovi-
sion and the density of Lim1+ cells in each section was
expressed in cells/mm2 retina. Statistical analyses were
performed in Prism (v3.02, GraphPad software Inc.) using
the Mann-Whitney test and p-values < 0.05 where consid-
ered significant (see also Additional file 3).
HC subtype quantification at P0: Z-stacks (~0, 4 μm inter-
vals) of the HCL were obtained from 20 μm thick retinal
cross sections stained for Lim1, Isl1, Ap2α combined with
Prox1, GABA, calretinin or TrkA using a 63× objective in a
LSM confocal microscope. Each Z-stack contained on
average 75 HCs. From 3 P0 chick retinas, at least 4 regions
in direct proximity to the optic nerve exit were photo-
graphed for each staining combination and the fractions
of single- or double positive cells within the stack were
counted manually using the LSM 510 imaging software.
Birth-dating of horizontal cell subtypes
Carefully staged embryos ranging from st19 to st33
received a single dose of tritiated deoxy-thymidine ([3H]-
dT, 1 μCi/μl, TRK758, Amersham). Stage 19–26 embryos
received 15 μCi, and st27-33 embryos received 25 μCi. A
minimum of three embryos per stage was used (except
stages 32 and 33, see Fig. 2). Embryos were allowed to
develop until st35, when the central most piece of retina
was punched out using a sharpened metal tube 4.5 mm in
diameter. Each retina was fixed (10 min, 4% PFA), washed
(10 min, PBS) and dissociated to a single-cell suspension
in 0,25% trypsin. Cells were pelleted and resuspended in
1 ml PBS (approximately 106 cells/ml). The cell suspen-
sions were plated onto 8-well slides (PH-098, NovaKemi
AB, Sweden, 50 μl/well) and air-dried. Slides were proc-
essed for Prox1 or Lim1 immunocytochemistry, using the
Vectastain Elite ABC-kit (PK-6102) and the 3,3'-diami-
nobensidine (DAB) peroxidase substrate kit (SK-4100)
from Vector Laboratories, according to the manufacturers
instructions. Slides were pre-treated in 0,5%
Cobalt(II)Chloride before the DAB reaction to maintain
DAB staining through the autoradiographic processing
[70]. Slides were dipped in EM Hypercoat Emulsion
(RPN41, GE Healthcare) and left to expose in darkness for
6–8 days at 4°C before being developed using Kodak D-
19 and Kodak Fixer (P6557, Sigma). Slides were mounted
in Entellan (Merck) and analysed by light microscopy.
The optimal exposure time was determined for each stage
and the threshold that was considered as a positive [3H]-
dT labelled cell was determined for each individual exper-
iment by identifying the most heavily [3H]-dT labelled
cells per sample and using those cells as reference (see
Additional file 1). On average, 260 immunolabelled cells
per stage and antibody were counted.
In addition to the round HCs with strong nuclear Prox1
labelling, weak Prox1 labelling is found within the INL at
st35 in elongated cells that are not HCs [33]. Therefore, a
distinction between Prox1+ HCs and non-HCs was made;
elongated faintly DAB-labelled cells were considered non-
HCs whereas rounded intensely nuclear DAB-labelled
cells were considered to be HCs (Additional file 1, com-
pare cells in A-B with cells in C). Only cells with intense
nuclear Prox1 labelling were counted.
Since Lim1+ HCs constitute half of all Prox1+ HCs at st35
(Fig. 1B), the raw data obtained from Lim1 cell counts
were divided by two. For example, if from one stage 15 out
of 25 Lim1+ cells were also [3H]-dT+, then this indicated
that 60% of the Lim1 expressing HCs were born around
this time. However, since Lim1+ HCs at the time of anal-
ysis (st35) constitute half of all HCs, this number actually
corresponds to 30% of all HCs with respect to Prox1.
Thus, to relate the fraction of [3H]-dT+ Lim1 cells to the
fraction of [3H]-dT+ Prox1 cells at the same stage, 30%
(and not 60%) would be the Lim1 percentage plotted in
figure 2 for that specific stage (see also Additional file 3).
Moreover, since we were unable to determine the birth-
curve of Isl1+ HCs directly, the numerical difference
between [3H]-dT+ Prox1 and Lim1 fractions were plotted
as a line to represent the birth-curve of Isl1+ HCs. Statisti-
cal analysis using the Student's t-tests were preformed at
every stage to test whether the [3H]-dT+ Prox1 and Lim1
fractions were significantly different (* p < 0.05).
TUNEL in combination with immunohistochemistry
To analyse cell death during retinal development we mod-
ified the protocol supplied with the DeadEnd Fluoromet-
ric TdT-mediated-dUTP-nick-end-labelling (TUNEL)
system (G3250, Promega) to be combined with immuno-
histochemistry. Sections were labelled for Prox1 and fixed
in 4% PFA prior to TUNEL staining, and secondary anti-
bodies were added after the TUNEL reaction. Retinas from
all stages between st20 and st36 but also stages 39, 41, 42,
44, P0, P4 and P7 were analysed. In addition, follistatin
and vehicle-treated retinas were analysed with respect to
Prox1 and TUNEL at st35-36 (E9–10).
Quantitative real time PCR
Total RNA was extracted from embryonic tissues using the
Trizol reagent (Invitrogen). Retinal tissue form stages 14,
16, 18, 21, 23, 25, 28, 30, 35, 38, 42 and 45 were used. For
st14-18, optic cups from 20–40 embryos were collected
and pooled with some contamination from lens and reti-
nal pigment epithelium. For embryos older than st18, 2–
14 retinas were collected and pooled. Two batches of
cDNA were prepared separately from 1 μg of RNA using
GeneAmp® (Applied Biosystems). Samples were run in
triplicate on both cDNA batches using IQ™ SyBr® Green
Supermix (Biorad) and normalized to β-actin and TATA-
box binding protein. Control reactions containing prim-
ers but no RNA were analysed in parallel. PrimerBMC Developmental Biology 2008, 8:46 http://www.biomedcentral.com/1471-213X/8/46
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sequences were; β-actin (NM205518; 5'-aggtcatcaccatt-
ggcaatg-3' and 5'-cccaagaaagatggctggaa-3'), TATA-box
binding protein (D83127; 5'-tagcccgatgatgccgtat-3' and 5'-
gttccctgtgtcgcttgc-3'), follistatin (NM205200, 5'-cgtcaac-
gacaacacgctctt-3' and 5'-ccaggtccacagtccacattct-3'), follista-
tin-like 1 (NM204638, 5'-attgtgagctgcaccgagatg-3' and 5'-
aactggactcgcagctggatt-3').
BrdU-assay in early activin-treated retinas
To test the effect of activin on retinal precursor cell prolif-
eration we injected st23 embryos with activin (PeproTech,
25–50 μg/ml in 5 mM citric acid) or vehicle as described
above. Five hours after injection, 100 μl of 10 mg/ml
BrdU (Sigma) was injected to the egg and 22 hours after
the initial injection, embryos were analysed for BrdU
incorporation by immunohistochemistry, with the modi-
fication that eyes were fixed in PFA for 1 hour. The
number of BrdU+ cells following activin (n = 5) or vehicle
treatment (n = 4) were quantified from a minimum of 4
cross-sections per embryo using Photoshop and ImageJ.
The area of the cross-sections of retina that were sampled
for labelled cells was determined using Axiovision and the
density of BrdU+ cells in each cross-section was expressed
in cells/mm2 retina. Statistical analyses was performed in
Prism (v3.02, GraphPad software Inc.) using the Mann-
Whitney test, p-value < 0.05 was considered significant.
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